The COST Action HyperChildNET (reference number CA 19115) is aimed at establishing a European sustainable and multidisciplinary network of internationally renowned researchers, clinicians, early career investigators, health economists, decision-makers, patients, regulatory bodies, nutrition & pharma companies and medical devices manufacturers focusing on acquiring a holistic understanding of the factors affecting high BP in children in order to propose and implement corrective and preventive actions both globally and locally.
All members of the network and the research projects running locally will collaborate by creating working groups to coordinate research actions, exchange scientific and clinical knowledge, research findings and best practices. In order to promote the research objectives foreseen, HyperChildNET will organise conferences, seminars, short-term scientific missions, training schools and will produce reports, studies, guides, strategy documents and action plans to make progress in contributing to solve the challenge.
Subscribe to our newsletter
COST is supported by the
EU Framework Programme Horizon 2020